SCI Pharmtech, Inc.

4119

TW0004119003

Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
90.4 ^TWD	+0.33%		+0.11%	-6.61%

06-13	SCI Pharmtech, Inc. Announces Cash Dividend on Common Stocks, Payable on August 05, 2024	CI
05-14	SCI Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

SCI Pharmtech, Inc. Announces Dividend, Payable on August 18, 2020

June 24, 2020 at 10:15 am

SCI Pharmtech, Inc. announced the cash dividends of TWD 461,014,798. Ex-rights (ex-dividend) trading date is July 13, 2020. Ex-rights (ex-dividend) record date is July 19, 2020. The payment date of the cash distribution is August 18, 2020.

Latest news about SCI Pharmtech, Inc.

SCI Pharmtech, Inc. Announces Cash Dividend on Common Stocks, Payable on August 05, 2024	06-13	CI
SCI Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
SCI Pharmtech, Inc. Announces Board Changes	05-09	CI
SCI Pharmtech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
SCI Pharmtech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
SCI Pharmtech, Inc. announced that it expects to receive TWD 120 million in funding	24/09/23	CI
SCI Pharmtech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/08/23	CI
SCI Pharmtech, Inc. Announces Cash Dividend, Payable on September 1, 2023	05/07/23	CI
SCI Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Sci Pharmtech, Inc. Proposes Cash Dividend for the Year Ended 31 December 2022	14/03/23	CI
SCI Pharmtech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	09/11/22	CI
SCI Pharmtech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	09/08/22	CI
SCI Pharmtech, Inc. Announces Appointment of General Manager of the Board of Directors	29/06/22	CI
SCI Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	06/05/22	CI
SCI Pharmtech, Inc. Proposes No Earnings Distribution for the Year Ended December 31, 2021	18/03/22	CI
SCI Pharmtech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	17/03/22	CI
SCI Pharmtech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	04/11/21	CI
Sci Pharmtech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	07/08/21	CI
Sci Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	06/05/21	CI
Sci Pharmtech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	23/03/21	CI
Sci Pharmtech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	05/08/20	CI
SCI Pharmtech, Inc. Announces Dividend, Payable on August 18, 2020	24/06/20	CI
Sci Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	07/05/20	CI
SCI Pharmtech, Inc. Proposes Dividend Distribution	13/03/20	CI
Sci Pharmtech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	12/03/20	CI

Chart SCI Pharmtech, Inc.

Duration

Period

More charts

Company Profile

SCI Pharmtech, Inc. is a Taiwan-based company principally engaged in the processing, manufacture and sales of Active Pharmaceutical Ingredients (APIs). The Company's main products include APIs, API intermediates and special and precision chemicals. The Company distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others

Sector

Pharmaceuticals

Calendar

07/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
SCI PHARMTECH, INC.	-6.61%	333M
MERCK KGAA	+7.39%	72.09B
KYOWA KIRIN CO. LTD.	+15.93%	9.05B
SK BIOPHARMACEUTICALS CO., LTD.	-22.81%	4.4B
YUHAN CORPORATION	+17.59%	4.39B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+25.93%	3.94B
INDIVIOR PLC	+4.64%	2.1B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+9.09%	1.97B
BETTA PHARMACEUTICALS CO., LTD.	-36.86%	1.87B
VELOXIS PHARMACEUTICALS A/S	-0.50%	1.64B

Specialty & Advanced Pharmaceuticals